Systemic immune-inflammation index and in-stent restenosis in patients with acute coronary syndrome: a single-center retrospective study

Abstract Background In-stent restenosis (ISR) has been shown to be correlated with inflammation. This study aimed to examine the relationship between systemic immune-inflammation index (SII, an innovative inflammatory biomarker) and ISR in acute coronary syndrome (ACS) patients after drug-eluting st...

Full description

Bibliographic Details
Main Authors: Feng Xie, Zuozhong Yu, Yurong Xiong, Zhijian Wu, Yanqing Wu
Format: Article
Language:English
Published: BMC 2024-02-01
Series:European Journal of Medical Research
Subjects:
Online Access:https://doi.org/10.1186/s40001-024-01736-4
_version_ 1797275373954662400
author Feng Xie
Zuozhong Yu
Yurong Xiong
Zhijian Wu
Yanqing Wu
author_facet Feng Xie
Zuozhong Yu
Yurong Xiong
Zhijian Wu
Yanqing Wu
author_sort Feng Xie
collection DOAJ
description Abstract Background In-stent restenosis (ISR) has been shown to be correlated with inflammation. This study aimed to examine the relationship between systemic immune-inflammation index (SII, an innovative inflammatory biomarker) and ISR in acute coronary syndrome (ACS) patients after drug-eluting stent (DES) implantation. Methods Subjects who were diagnosed with ACS and underwent DES implantation were enrolled retrospectively. All individuals underwent follow-up coronary angiography at six to forty-eight months after percutaneous coronary intervention (PCI). SII was defined as [(platelet count × neutrophil count)/lymphocyte count], and Ln-transformed SII (LnSII) was carried out for our analysis. Multivariate logistic regression analysis was employed to assess the association between LnSII and DES-ISR. Results During a median follow-up period of 12 (11, 20) months, 523 ACS patients who underwent follow-up angiography were included. The incidence of DES-ISR was 11.28%, and patients in the higher LnSII tertile trended to show higher likelihoods of ISR (5.7% vs. 12.1% vs. 16.0%; P = 0.009). Moreover, each unit of increased LnSII was correlated with a 69% increased risk of DES-ISR (OR = 1.69, 95% CI 1.04–2.75). After final adjusting for confounders, a significant higher risk of DES-ISR (OR = 2.52, 95% CI 1.23–5.17) was found in participants in tertile 3 (≥ 6.7), compared with those in tertiles 1–2 (< 6.7). Subgroup analysis showed no significant dependence on age, gender, body mass index, current smoking, hypertension, and diabetes for this positive association (all P for interaction > 0.05). Conclusion High levels of SII were independently associated with an increased risk of DES-ISR in ACS patients who underwent PCI. Further prospective cohort studies are still needed to validate our findings.
first_indexed 2024-03-07T15:13:26Z
format Article
id doaj.art-cc5db2a7e3504ca388b506472cc11f6f
institution Directory Open Access Journal
issn 2047-783X
language English
last_indexed 2024-03-07T15:13:26Z
publishDate 2024-02-01
publisher BMC
record_format Article
series European Journal of Medical Research
spelling doaj.art-cc5db2a7e3504ca388b506472cc11f6f2024-03-05T18:04:21ZengBMCEuropean Journal of Medical Research2047-783X2024-02-0129111010.1186/s40001-024-01736-4Systemic immune-inflammation index and in-stent restenosis in patients with acute coronary syndrome: a single-center retrospective studyFeng Xie0Zuozhong Yu1Yurong Xiong2Zhijian Wu3Yanqing Wu4Department of Cardiology, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang UniversityDepartment of Cardiology, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang UniversityDepartment of Cardiology, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang UniversityDepartment of Cardiology, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang UniversityDepartment of Cardiology, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang UniversityAbstract Background In-stent restenosis (ISR) has been shown to be correlated with inflammation. This study aimed to examine the relationship between systemic immune-inflammation index (SII, an innovative inflammatory biomarker) and ISR in acute coronary syndrome (ACS) patients after drug-eluting stent (DES) implantation. Methods Subjects who were diagnosed with ACS and underwent DES implantation were enrolled retrospectively. All individuals underwent follow-up coronary angiography at six to forty-eight months after percutaneous coronary intervention (PCI). SII was defined as [(platelet count × neutrophil count)/lymphocyte count], and Ln-transformed SII (LnSII) was carried out for our analysis. Multivariate logistic regression analysis was employed to assess the association between LnSII and DES-ISR. Results During a median follow-up period of 12 (11, 20) months, 523 ACS patients who underwent follow-up angiography were included. The incidence of DES-ISR was 11.28%, and patients in the higher LnSII tertile trended to show higher likelihoods of ISR (5.7% vs. 12.1% vs. 16.0%; P = 0.009). Moreover, each unit of increased LnSII was correlated with a 69% increased risk of DES-ISR (OR = 1.69, 95% CI 1.04–2.75). After final adjusting for confounders, a significant higher risk of DES-ISR (OR = 2.52, 95% CI 1.23–5.17) was found in participants in tertile 3 (≥ 6.7), compared with those in tertiles 1–2 (< 6.7). Subgroup analysis showed no significant dependence on age, gender, body mass index, current smoking, hypertension, and diabetes for this positive association (all P for interaction > 0.05). Conclusion High levels of SII were independently associated with an increased risk of DES-ISR in ACS patients who underwent PCI. Further prospective cohort studies are still needed to validate our findings.https://doi.org/10.1186/s40001-024-01736-4In-stent restenosisDrug-eluting stentsSystemic immune-inflammation indexAcute coronary syndromePercutaneous coronary intervention
spellingShingle Feng Xie
Zuozhong Yu
Yurong Xiong
Zhijian Wu
Yanqing Wu
Systemic immune-inflammation index and in-stent restenosis in patients with acute coronary syndrome: a single-center retrospective study
European Journal of Medical Research
In-stent restenosis
Drug-eluting stents
Systemic immune-inflammation index
Acute coronary syndrome
Percutaneous coronary intervention
title Systemic immune-inflammation index and in-stent restenosis in patients with acute coronary syndrome: a single-center retrospective study
title_full Systemic immune-inflammation index and in-stent restenosis in patients with acute coronary syndrome: a single-center retrospective study
title_fullStr Systemic immune-inflammation index and in-stent restenosis in patients with acute coronary syndrome: a single-center retrospective study
title_full_unstemmed Systemic immune-inflammation index and in-stent restenosis in patients with acute coronary syndrome: a single-center retrospective study
title_short Systemic immune-inflammation index and in-stent restenosis in patients with acute coronary syndrome: a single-center retrospective study
title_sort systemic immune inflammation index and in stent restenosis in patients with acute coronary syndrome a single center retrospective study
topic In-stent restenosis
Drug-eluting stents
Systemic immune-inflammation index
Acute coronary syndrome
Percutaneous coronary intervention
url https://doi.org/10.1186/s40001-024-01736-4
work_keys_str_mv AT fengxie systemicimmuneinflammationindexandinstentrestenosisinpatientswithacutecoronarysyndromeasinglecenterretrospectivestudy
AT zuozhongyu systemicimmuneinflammationindexandinstentrestenosisinpatientswithacutecoronarysyndromeasinglecenterretrospectivestudy
AT yurongxiong systemicimmuneinflammationindexandinstentrestenosisinpatientswithacutecoronarysyndromeasinglecenterretrospectivestudy
AT zhijianwu systemicimmuneinflammationindexandinstentrestenosisinpatientswithacutecoronarysyndromeasinglecenterretrospectivestudy
AT yanqingwu systemicimmuneinflammationindexandinstentrestenosisinpatientswithacutecoronarysyndromeasinglecenterretrospectivestudy